Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Preparation of Polymer-Based Nanoparticles

Posted on By

SOP for Preparation of Polymer-Based Nanoparticles

Standard Operating Procedure for Preparation of Polymer-Based Nanoparticles

1) Purpose

This SOP describes the process for preparing polymer-based nanoparticles, commonly used for drug delivery and other biomedical applications. It aims to ensure a consistent and high-quality preparation process.

2) Scope

This SOP applies to laboratory personnel involved in the preparation and processing of polymer-based nanoparticles in the research or production setting.

3) Responsibilities

  • Operators: Responsible for the accurate preparation and processing of polymer-based nanoparticles according to this SOP.
  • QA: Ensures compliance with protocols and verifies the quality of prepared nanoparticles.

4) Procedure

4.1 Polymer Preparation

4.1.1 Polymer Selection

  • 4.1.1.1 Select appropriate polymers (e.g., PLGA, PEG) based on the desired properties of the nanoparticles (e.g., size, degradation rate).
  • 4.1.1.2 Verify the quality of the polymer by reviewing certificates of analysis and performing any necessary pre-processing checks.
See also  Nanoparticle Formulation : SOP for Preparation of Magnetic Nanoparticles for Biomedical Applications

4.1.2 Polymer Dissolution

  • 4.1.2.1 Dissolve the polymer in an appropriate solvent (e.g., acetone or ethanol) under continuous stirring until fully solubilized.
  • 4.1.2.2 If heating is required, ensure the temperature does not exceed the polymer’s thermal stability.

4.2 Nanoparticle Formation

4.2.1 Emulsification

  • 4.2.1.1 Slowly add the polymer solution to an aqueous phase containing stabilizers under high-speed homogenization to form an emulsion.
  • 4.2.1.2 Continue mixing for 10–15 minutes to stabilize the emulsion.

4.2.2 Solvent Evaporation

  • 4.2.2.1 Allow the solvent to evaporate under reduced
pressure or by stirring at room temperature, leading to nanoparticle formation as the polymer precipitates.
  • 4.2.2.2 Monitor particle size using dynamic light scattering (DLS) or other particle-sizing methods.
  • 4.3 Collection and Washing of Nanoparticles

    4.3.1 Centrifugation

    • 4.3.1.1 Centrifuge the nanoparticle suspension at 10,000–20,000 g for 20–30 minutes to collect the nanoparticles.
    • 4.3.1.2 Discard the supernatant and wash the nanoparticles by resuspending them in distilled water and repeating the centrifugation process.

    4.4 Storage of Nanoparticles

    4.4.1 Storage Conditions

    • 4.4.1.1 Store the polymer-based nanoparticles in sterile, sealed containers at 4°C or freeze them for long-term storage, depending on the stability of the formulation.

    5) Abbreviations, if any

    • DLS: Dynamic Light Scattering
    • PLGA: Poly(lactic-co-glycolic acid)
    • PEG: Polyethylene glycol
    • PPE: Personal Protective Equipment

    6) Documents, if any

    • Polymer-Based Nanoparticle Preparation Logbook

    7) References, if any

    • Polymer Material Safety Data Sheets (MSDS)

    8) SOP Version

    Version 1.0

    Annexure

    Polymer-Based Nanoparticle Preparation Logbook Template

    Date Batch Number Polymer Type Particle Size Encapsulation Efficiency Operator Initials QA Initials
    DD/MM/YYYY Batch Number Polymer Name Size in nm % Encapsulation Operator Name QA Name
               
    See also  SOP for Preparation and Handling of Nanoparticle Precursors
    Nanoparticle Formulation Tags:Nanoparticle biomedical applications SOP, Nanoparticle clinical trial SOP, Nanoparticle encapsulation SOP, Nanoparticle formulation SOP, Nanoparticle handling SOP, Nanoparticle preparation procedure, Nanoparticle production SOP, Nanoparticle quality control SOP, Nanoparticle size optimization SOP, Nanoparticle SOP, Nanoparticle stability testing SOP, Nanoparticle standard operating procedures, Nanoparticle sterilization SOP, Nanoparticle storage SOP, Nanoparticle surface modification SOP, Nanoparticle synthesis SOP, Nanoparticle toxicology SOP, SOP for nanomaterials, SOP for nanoparticle characterization, SOP for nanoparticle drug delivery, SOP for nanoparticle gene delivery, SOP for nanoparticle regulatory compliance, SOP for nanoparticle safety, SOP for nanoparticle scaling, SOP for targeted drug delivery nanoparticles

    Post navigation

    Previous Post: SOP for Preparation of Lipid-Based Nanoparticles
    Next Post: SOP for Formulation of Sustained Release Nasal Sprays

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version